Infectious Diseases

Infection in Immunocompromised Pediatric Patients

Pere Soler Palacin

Summary

As a consolidated research group at VHIR and an AGAUR emerging research group, we have become established in 2015. The group has integrated the site of Drassanes-PROSICS in order to incorporate imported diseases and tuberculosis to our research lines, expanding the range of projects in which the group has been involved. Therefore, the number of publications and their impact factor has increased, an increment that will become even more noticeable along 2016.

The group has participated in several international projects and it’s currently leading national and international projects in the fields of primary immunodeficiencies, tuberculosis and community-acquired infections.

We are extremely proud of the growth of the Immunology Collection at VHIR’s Biobank with more than 100 samples by the end of 2015. This accomplishment has been achieved with the invaluable assistance of the Catalan Association of Primary Immunodeficiencies (ACADIP) and the Barcelona-PID Foundation, following our key principle to perform a translational and patient-centred research.

Publications

total

41^.5

impact factor

3^.458

average impact factor

Selected articles+

Cobos-Carrascosa E, Soler-Palacín P, Nieves Larrosa M, Bartolomé R, Martín-Nalda A, Antoinette Frick M, Bernet A, Pumarola T, Figueras-Nadal C. Staphylococcus aureus Bacteremia in Children: Changes During Eighteen Years. Pediatr Infect Dis J. 2015 Dec;34(12):1329-34.
Bode SF, Ammann S, Al-Herz W, Bataneant M, Dvorak CC, Gehring S, Gennery A, Gilmour KC, Gonzalez-Granado LI, Groß-Wieltsch U, Ifversen M, Lingman-Framme J, Matthes-Martin S, Mesters R, Meyts I, van Montfrans JM, Pachlopnik Schmid J, Pai SY,Soler-PalacinP, Schuermann U, Schuster V, Seidel MG, Speckmann C, Stepensky P, Sykora KW, Tesi B, Vraetz T, Waruiru C, Bryceson YT, Moshous D, Lehmberg K, Jordan MB, Ehl S; Inborn Errors Working Party of the EBMT. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. Haematologica. 2015 Jul;100(7):978-88
Palladino C, Gómez ML, Soler-Palacín P, González-Tomé MI, De Ory SJ, Espiau M, Hoyos SP, León-Leal JA, Méndez M, Moreno-Pérez D, Guasch CF, Sierra AM, Guruceta IP, Guillén SM, Briz V; CoRISpe Working Group. Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practice. AIDS. 2015 Oct 23;29(16):2155-9.
Kurth F, Develoux M, Mechain M, Clerinx J, Antinori S, Gjørup IE, Gascon J, Mørch K, Nicastri E, Ramharter M, Bartoloni A, Visser L, Rolling T, Zanger P, Calleri G, Salas-Coronas J, Nielsen H, Just-Nübling G, Neumayr A, Hachfeld A, Schmid ML, Antonini P, Pongratz P, Kern P, Saraiva da Cunha J, Soriano-ArandesA, Schunk M, Suttorp N, Hatz C, Zoller T; TropNet Severe Malaria Investigator Group.Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study. Clin Infect Dis. 2015 Nov 1;61(9):1441-4.
Altet N, Dominguez J, Souza-Galvão ML, Jiménez-Fuentes MÁ, Milà C, Solsona J, Soriano-Arandés A, Latorre I, Lara E, Cantos A, Ferrer MD, Orcau À, Ruiz-Manzano J, Caylà J. Predicting the Development of Tuberculosis with the Tuberculin Skin Test and QuantiFERON Testing. Ann Am Thorac Soc. 2015 May;12(5):680-8.

[ View all publications ]

Main research projects

View+